Demographic, psychosocial, and clinical disease activity measures for patients in remission at the 1-and 3-year follow-ups.
| Year 1 | Year 3 | |||||
| IBS | No IBS | P-value | IBS | No IBS | P-value | |
| n = 62 (21.9%) | n = 221 (78.3%) | n = 49 (16.1%) | n = 255 (83.9%) | |||
| Demographic | ||||||
| Age in years (SD) | 41 (14) | 46 (15) | .030 | 45 (13) | 47 (15) | .530 |
| Sex | ||||||
| Female, n (%) | 47 (75.8) | 109 (49.3) | <.001 | 31 (63.3) | 126 (49.4) | .087 |
| Male, n (%) | 15 (24.2) | 112 (50.7) | 18 (36.7) | 129 (50.6) | ||
| Diagnosis | ||||||
| UC, n (%) | 44 (71.0) | 156 (70.6) | 1.000 | 35 (71.4) | 177 (69.4) | .866 |
| CD, n (%) | 18 (29.0) | 65 (29.4) | 14 (28.6) | 78 (30.6) | ||
| Psychosocial measures | ||||||
| HADS-A, median (range) | 6 (0-16) | 5 (0-18) | .009 | 7 (0-15) | 4 (0-18) | <.001 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| HADS-D, median (range) | 4 (0-14) | 2 (0-14) | .001 | 4 (0-15) | 2 (0-15) | .002 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| GSE, median (range) | 29 (13-39) | 30 (10-40) | .044 | 28 (18-40) | 31 (10-40) | <.001 |
| Missing, n (%) | – | – | – | 1 (0.4) | ||
| FQ, median (range) | 7 (0-11) | 2 (0-11) | <.001 | 4 (0-11) | 2 (0-11) | <.001 |
| Missing, n (%) | – | 1 (0.5) | – | 4 (1.6) | ||
| Clinical disease activity measures | ||||||
| CRP, median (range) | 2.0 (0-15) | 1.8 (0-31) | .662 | |||
| Missing, n (%) | 7 (11.3) | 28 (12.7) | ||||
| HBI CD, median (range) | 5 (0-11) | 1 (0-6) | <.001 | 4 (1-11) | 2 (0-12) | .002 |
| Missing, n (%) | 5 (27.8) | 8 (12.3) | – | 1 (1.3) | ||
| SCCAI UC, median (range) | 2.0 (0-11) | 0 (0-8) | <.001 | 2 (0-8) | 1 (0-12) | <.001 |
| Missing, n (%) | 4 (9.1) | 12 (7.7) | 1 (2.9) | 4 (2.3) | ||
| Year 1 | Year 3 | |||||
| IBS | No IBS | P-value | IBS | No IBS | P-value | |
| n = 62 (21.9%) | n = 221 (78.3%) | n = 49 (16.1%) | n = 255 (83.9%) | |||
| Demographic | ||||||
| Age in years (SD) | 41 (14) | 46 (15) | .030 | 45 (13) | 47 (15) | .530 |
| Sex | ||||||
| Female, n (%) | 47 (75.8) | 109 (49.3) | <.001 | 31 (63.3) | 126 (49.4) | .087 |
| Male, n (%) | 15 (24.2) | 112 (50.7) | 18 (36.7) | 129 (50.6) | ||
| Diagnosis | ||||||
| UC, n (%) | 44 (71.0) | 156 (70.6) | 1.000 | 35 (71.4) | 177 (69.4) | .866 |
| CD, n (%) | 18 (29.0) | 65 (29.4) | 14 (28.6) | 78 (30.6) | ||
| Psychosocial measures | ||||||
| HADS-A, median (range) | 6 (0-16) | 5 (0-18) | .009 | 7 (0-15) | 4 (0-18) | <.001 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| HADS-D, median (range) | 4 (0-14) | 2 (0-14) | .001 | 4 (0-15) | 2 (0-15) | .002 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| GSE, median (range) | 29 (13-39) | 30 (10-40) | .044 | 28 (18-40) | 31 (10-40) | <.001 |
| Missing, n (%) | – | – | – | 1 (0.4) | ||
| FQ, median (range) | 7 (0-11) | 2 (0-11) | <.001 | 4 (0-11) | 2 (0-11) | <.001 |
| Missing, n (%) | – | 1 (0.5) | – | 4 (1.6) | ||
| Clinical disease activity measures | ||||||
| CRP, median (range) | 2.0 (0-15) | 1.8 (0-31) | .662 | |||
| Missing, n (%) | 7 (11.3) | 28 (12.7) | ||||
| HBI CD, median (range) | 5 (0-11) | 1 (0-6) | <.001 | 4 (1-11) | 2 (0-12) | .002 |
| Missing, n (%) | 5 (27.8) | 8 (12.3) | – | 1 (1.3) | ||
| SCCAI UC, median (range) | 2.0 (0-11) | 0 (0-8) | <.001 | 2 (0-8) | 1 (0-12) | <.001 |
| Missing, n (%) | 4 (9.1) | 12 (7.7) | 1 (2.9) | 4 (2.3) | ||
Results are presented as percentages for categorical variables, mean (SD) for age, and median values with ranges for all other continuous variables. The number of study participants with missing data are also shown for each variable.
Abbreviations: CD, Crohn’s disease; CRP, C-reactive protein; FQ, fatigue questionnaire; GSE, general self-efficacy; HADS, Hospital Anxiety and Depression Scale; HADS-A, anxiety subscale; HADS-D, depression subscale; HBI, Harvey-Bradshaw Index; IBS, irritable bowel syndrome; SCCAI, Simple Clinical Colitis Activity Index; UC, ulcerative colitis.
Demographic, psychosocial, and clinical disease activity measures for patients in remission at the 1-and 3-year follow-ups.
| Year 1 | Year 3 | |||||
| IBS | No IBS | P-value | IBS | No IBS | P-value | |
| n = 62 (21.9%) | n = 221 (78.3%) | n = 49 (16.1%) | n = 255 (83.9%) | |||
| Demographic | ||||||
| Age in years (SD) | 41 (14) | 46 (15) | .030 | 45 (13) | 47 (15) | .530 |
| Sex | ||||||
| Female, n (%) | 47 (75.8) | 109 (49.3) | <.001 | 31 (63.3) | 126 (49.4) | .087 |
| Male, n (%) | 15 (24.2) | 112 (50.7) | 18 (36.7) | 129 (50.6) | ||
| Diagnosis | ||||||
| UC, n (%) | 44 (71.0) | 156 (70.6) | 1.000 | 35 (71.4) | 177 (69.4) | .866 |
| CD, n (%) | 18 (29.0) | 65 (29.4) | 14 (28.6) | 78 (30.6) | ||
| Psychosocial measures | ||||||
| HADS-A, median (range) | 6 (0-16) | 5 (0-18) | .009 | 7 (0-15) | 4 (0-18) | <.001 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| HADS-D, median (range) | 4 (0-14) | 2 (0-14) | .001 | 4 (0-15) | 2 (0-15) | .002 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| GSE, median (range) | 29 (13-39) | 30 (10-40) | .044 | 28 (18-40) | 31 (10-40) | <.001 |
| Missing, n (%) | – | – | – | 1 (0.4) | ||
| FQ, median (range) | 7 (0-11) | 2 (0-11) | <.001 | 4 (0-11) | 2 (0-11) | <.001 |
| Missing, n (%) | – | 1 (0.5) | – | 4 (1.6) | ||
| Clinical disease activity measures | ||||||
| CRP, median (range) | 2.0 (0-15) | 1.8 (0-31) | .662 | |||
| Missing, n (%) | 7 (11.3) | 28 (12.7) | ||||
| HBI CD, median (range) | 5 (0-11) | 1 (0-6) | <.001 | 4 (1-11) | 2 (0-12) | .002 |
| Missing, n (%) | 5 (27.8) | 8 (12.3) | – | 1 (1.3) | ||
| SCCAI UC, median (range) | 2.0 (0-11) | 0 (0-8) | <.001 | 2 (0-8) | 1 (0-12) | <.001 |
| Missing, n (%) | 4 (9.1) | 12 (7.7) | 1 (2.9) | 4 (2.3) | ||
| Year 1 | Year 3 | |||||
| IBS | No IBS | P-value | IBS | No IBS | P-value | |
| n = 62 (21.9%) | n = 221 (78.3%) | n = 49 (16.1%) | n = 255 (83.9%) | |||
| Demographic | ||||||
| Age in years (SD) | 41 (14) | 46 (15) | .030 | 45 (13) | 47 (15) | .530 |
| Sex | ||||||
| Female, n (%) | 47 (75.8) | 109 (49.3) | <.001 | 31 (63.3) | 126 (49.4) | .087 |
| Male, n (%) | 15 (24.2) | 112 (50.7) | 18 (36.7) | 129 (50.6) | ||
| Diagnosis | ||||||
| UC, n (%) | 44 (71.0) | 156 (70.6) | 1.000 | 35 (71.4) | 177 (69.4) | .866 |
| CD, n (%) | 18 (29.0) | 65 (29.4) | 14 (28.6) | 78 (30.6) | ||
| Psychosocial measures | ||||||
| HADS-A, median (range) | 6 (0-16) | 5 (0-18) | .009 | 7 (0-15) | 4 (0-18) | <.001 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| HADS-D, median (range) | 4 (0-14) | 2 (0-14) | .001 | 4 (0-15) | 2 (0-15) | .002 |
| Missing, n (%) | – | – | – | 2 (0.8) | ||
| GSE, median (range) | 29 (13-39) | 30 (10-40) | .044 | 28 (18-40) | 31 (10-40) | <.001 |
| Missing, n (%) | – | – | – | 1 (0.4) | ||
| FQ, median (range) | 7 (0-11) | 2 (0-11) | <.001 | 4 (0-11) | 2 (0-11) | <.001 |
| Missing, n (%) | – | 1 (0.5) | – | 4 (1.6) | ||
| Clinical disease activity measures | ||||||
| CRP, median (range) | 2.0 (0-15) | 1.8 (0-31) | .662 | |||
| Missing, n (%) | 7 (11.3) | 28 (12.7) | ||||
| HBI CD, median (range) | 5 (0-11) | 1 (0-6) | <.001 | 4 (1-11) | 2 (0-12) | .002 |
| Missing, n (%) | 5 (27.8) | 8 (12.3) | – | 1 (1.3) | ||
| SCCAI UC, median (range) | 2.0 (0-11) | 0 (0-8) | <.001 | 2 (0-8) | 1 (0-12) | <.001 |
| Missing, n (%) | 4 (9.1) | 12 (7.7) | 1 (2.9) | 4 (2.3) | ||
Results are presented as percentages for categorical variables, mean (SD) for age, and median values with ranges for all other continuous variables. The number of study participants with missing data are also shown for each variable.
Abbreviations: CD, Crohn’s disease; CRP, C-reactive protein; FQ, fatigue questionnaire; GSE, general self-efficacy; HADS, Hospital Anxiety and Depression Scale; HADS-A, anxiety subscale; HADS-D, depression subscale; HBI, Harvey-Bradshaw Index; IBS, irritable bowel syndrome; SCCAI, Simple Clinical Colitis Activity Index; UC, ulcerative colitis.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
